Analyst Ratings For Ionis Pharmaceuticals (NASDAQ:IONS)
Today, Sanford C. Bernstein initiated coverage on Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform with a price target of $57.00.
There are 2 sell ratings, 7 hold ratings, 6 buy ratings on the stock.
The current consensus rating on Ionis Pharmaceuticals (NASDAQ:IONS) is Hold (Score: 2.27) with a consensus target price of $45.00 per share, a potential 17.17% downside.
Some recent analyst ratings include
- 7/27/2017-Sanford C. Bernstein initiated coverage with a Market Perform rating.
- 7/26/2017-Needham & Company LLC Reiterated Rating of Buy.
- 7/25/2017-BMO Capital Markets Reiterated Rating of Outperform.
- 7/10/2017-Stifel Nicolaus Reiterated Rating of Hold.
- 5/22/2017-Cowen and Company Reiterated Rating of Market Perform.
- 5/17/2017-Leerink Swann Reiterated Rating of Outperform.
Recent Insider Trading Activity For Ionis Pharmaceuticals (NASDAQ:IONS)
Ionis Pharmaceuticals (NASDAQ:IONS) has insider ownership of 1.86% and institutional ownership of 88.75%.
- On 7/24/2017 C Frank Bennett, SVP, sold 10,000 with an average share price of $59.29 per share and the total transaction amounting to $592,900.00. View SEC Filing
- On 7/20/2017 Stanley T Crooke, Chairman, sold 11,000 with an average share price of $55.35 per share and the total transaction amounting to $608,850.00. View SEC Filing
- On 7/19/2017 Ionis Pharmaceuticals Inc, Major Shareholder, bought 3,125,000 with an average share price of $8.00 per share and the total transaction amounting to $25,000,000.00. View SEC Filing
- On 7/17/2017 Stanley T Crooke, Chairman, sold 16,500 with an average share price of $52.45 per share and the total transaction amounting to $865,425.00. View SEC Filing
- On 7/3/2017 Brett P Monia, SVP, sold 309 with an average share price of $51.35 per share and the total transaction amounting to $15,867.15. View SEC Filing
- On 7/3/2017 Stanley T Crooke, Chairman, sold 16,500 with an average share price of $52.10 per share and the total transaction amounting to $859,650.00. View SEC Filing
- On 6/1/2017 Patrick R O’neil, SVP, sold 70 with an average share price of $48.00 per share and the total transaction amounting to $3,360.00. View SEC Filing
Recent Trading Activity for Ionis Pharmaceuticals (NASDAQ:IONS)
Shares of Ionis Pharmaceuticals closed the previous trading session at 53.89 down -0.44 -0.81% with 1,482,874 shares trading hands.